MBRS-26. WHOLE EXOME SEQUENCING OF CIRCULATING TUMOR DNA EXTRACTED FROM THE CEREBROSPINAL FLUID ALLOWS A PANGENOMIC CHARACTERISTISATION OF THE PRIMARY TUMOR. Issue 2 (22nd June 2018)
- Record Type:
- Journal Article
- Title:
- MBRS-26. WHOLE EXOME SEQUENCING OF CIRCULATING TUMOR DNA EXTRACTED FROM THE CEREBROSPINAL FLUID ALLOWS A PANGENOMIC CHARACTERISTISATION OF THE PRIMARY TUMOR. Issue 2 (22nd June 2018)
- Main Title:
- MBRS-26. WHOLE EXOME SEQUENCING OF CIRCULATING TUMOR DNA EXTRACTED FROM THE CEREBROSPINAL FLUID ALLOWS A PANGENOMIC CHARACTERISTISATION OF THE PRIMARY TUMOR
- Authors:
- Chicard, Mathieu
Combaret, Valérie
Danzon, Adrien
Clément, Nathalie
Masliah-Planchon, Julien
Bohec, Mylène
Baulande, Sylvain
Pouponnot, Célio
Frappaz, Didier
Doz, François
Delattre, Olivier
Schleiermacher, Gudrun
Bourdeaut, Franck - Abstract:
- Abstract: BACKGROUND: Liquid biopsies are revolutionary tools to detect tumour-specific genetic alterations in body fluids. Here, we assess whether the circulating tumor DNA (ctDNA) in Cerebral Spinal Fluid (CSF) could be used for tumor genetic profiling of Medulloblastomas (MB). METHODS: We extracted the ctDNA of 4-5 CSF droplets after lumbar puncture from patients with Medulloblastoma (12), or ETMR (1). ctDNA (quantity mean 30ng; range 8-177ng) and matched genomic DNA from primary tumors were sequenced by Whole Exome Sequencing (WES) (Illumina 100PE) using Nimblegen Medexome Capture. SNVs/mutations were called using GATK-UnifiedGenotyper, GATK-HaplotypeCaller and Samtools, and filtered on constitutional DNA from public databases. Copy Number profiles were generated with CNVkits. RESULTS: 10/13 cfDNA WES yielded satisfactory depth (>10x). A mean of 466 (range 93-945) SNVs were detected in the primary tumor and 474 (range 18-922) in the CSF. A mean of 416 (range 18-872) commons SNVs were observed between the cfDNA and the primary tumor, comprising classical Medulloblastoma genes such as SMO or MLL2. Interestingly, several SNVs were observed either in the tumor only (mean 50; range 3-115) or in CSF only (mean 58; range 0-148) suggesting a clonal heterogeneity. For 5 cases, Copy Number profiles were also available, allowing the detection of MYCN amplification in 1 MB or 19q13 miRNA cluster amplification in the ETMR.
- Is Part Of:
- Neuro-oncology. Volume 20:Issue 2(2018)supplement 2
- Journal:
- Neuro-oncology
- Issue:
- Volume 20:Issue 2(2018)supplement 2
- Issue Display:
- Volume 20, Issue 2 (2018)
- Year:
- 2018
- Volume:
- 20
- Issue:
- 2
- Issue Sort Value:
- 2018-0020-0002-0000
- Page Start:
- i133
- Page End:
- i134
- Publication Date:
- 2018-06-22
- Subjects:
- Brain Neoplasms -- Periodicals
Brain -- Tumors -- Periodicals
Brain -- Cancer -- Periodicals
Nervous system -- Cancer -- Periodicals
616.99481 - Journal URLs:
- http://neuro-oncology.dukejournals.org/ ↗
http://neuro-oncology.oxfordjournals.org/ ↗
http://www.oxfordjournals.org/content?genre=journal&issn=1522-8517 ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/neuonc/noy059.471 ↗
- Languages:
- English
- ISSNs:
- 1522-8517
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.288000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12322.xml